Alice Pomponio
Managing Director, BrightEdge and Vice President Innovation and Impact Investing, American Cancer Society
Alice is an impact investor, social innovation entrepreneur, and patient advocate with extensive experience in life sciences and business, coupled with her passion for the American Cancer Society’s lifesaving mission. She leads BrightEdge, ACS's venture capital and impact investment arm. Her ACS volunteer leadership includes past Chair Eastern New England Board of Directors and National Board Member of American Cancer Society Cancer Action Network. She is on faculty at Harvard-MIT HST Sloan Healthcare Ventures where she teaches biomedical innovation and healthcare entrepreneurship. Alice held prior R&D and commercial leadership roles at Radius Health, AstraZeneca, and Sanofi Genzyme, where she launched multiple U.S. and global specialty products and championed orphan drug policy and health equity initiatives across the globe. She led open innovation and public-private partnerships that have transformed specialty medicines development. Her public sector experience spans innovation, trade, and healthcare policy through roles in the UK Government and U.S. Office of Management and Budget. She holds a Master of Public Policy from Harvard University and a Bachelor of Science in Biology from MIT.
